51 related articles for article (PubMed ID: 16434379)
1. Graft versus host disease-dependent renal dysfunction after hematopoietic stem cell transplantation.
Motoyoshi Y; Endo A; Takagi M; Morio T; Ito E; Nagata M; Mizutani S
CEN Case Rep; 2014 Nov; 3(2):202-205. PubMed ID: 28509199
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis.
Auger-Quittet S; Duny Y; Daures JP; Quittet P
Cancer Med; 2014 Aug; 3(4):927-38. PubMed ID: 24740968
[TBL] [Abstract][Full Text] [Related]
3. Update on the role of autologous hematopoietic stem cell transplantation in follicular lymphoma.
Cabrero M; Redondo A; Martin A; Caballero D
Mediterr J Hematol Infect Dis; 2012; 4(1):e2012074. PubMed ID: 23205262
[TBL] [Abstract][Full Text] [Related]
4. Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.
Reddy N; Oluwole O; Greer JP; Goodman S; Engelhardt B; Jagasia MH; Savani BN
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):406-11. PubMed ID: 22981964
[TBL] [Abstract][Full Text] [Related]
5. Second-line treatment paradigms for diffuse large B-cell lymphomas.
Thieblemont C; Gisselbrecht C
Curr Oncol Rep; 2009 Sep; 11(5):386-93. PubMed ID: 19679014
[TBL] [Abstract][Full Text] [Related]
6. Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Kang BW; Kim WS; Kim C; Jang G; Lee SS; Choi YH; Lee DH; Kim SW; Kim S; Ryu JS; Huh J; Lee JS; Suh C
Invest New Drugs; 2010 Aug; 28(4):516-22. PubMed ID: 19547918
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid reconstruction and vaccines.
Gress RE; Komanduri KV; Einsele H; Cooper LJ
Biol Blood Marrow Transplant; 2007 Jan; 13(1 Suppl 1):17-22. PubMed ID: 17222765
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas.
Cilley J; Winter JN
Haematologica; 2006 Jan; 91(1):114-20. PubMed ID: 16434379
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapeutic strategies in autologous hematopoietic stem-cell transplantation for malignant lymphoma.
Inwards DJ; Cilley JC; Winter JN
Best Pract Res Clin Haematol; 2006; 19(4):669-84. PubMed ID: 16997176
[TBL] [Abstract][Full Text] [Related]
10. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
Nademanee A; Forman SJ
Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy and Autologous Stem-Cell Transplantation in the Treatment of B-Cell Non-Hodgkin Lymphoma.
Shimoni A; Zwas ST
Semin Nucl Med; 2016 Mar; 46(2):119-25. PubMed ID: 26897716
[TBL] [Abstract][Full Text] [Related]
12. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M
Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Nowakowski GS; Witzig TE
Clin Adv Hematol Oncol; 2006 Mar; 4(3):225-31. PubMed ID: 16728934
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
